Chile Radiotherapy

Chile Radiotherapy Market Outlook

The global radiotherapy market is poised for significant growth, with projections indicating a market size of approximately USD 8.2 billion by 2035, expanding at a compound annual growth rate (CAGR) of around 6.2% during the forecast period from 2025 to 2035. This growth is largely driven by the increasing incidence of cancer, advancements in radiotherapy technology, and the rising demand for effective cancer treatment options. Moreover, the expansion of healthcare infrastructure in emerging economies, including Chile, combined with growing awareness regarding early detection and treatment of cancer, further fuels the market's momentum. The advent of innovative therapies and treatment modalities is also expected to positively influence market dynamics, leading to enhanced patient outcomes and expanded access to radiotherapy services.

Growth Factor of the Market

The Chile radiotherapy market is influenced by several key growth factors that are shaping its trajectory. Firstly, the prevalence of cancer in Chile has been on the rise, prompting an urgent need for effective treatment modalities such as radiotherapy. Government initiatives aimed at improving healthcare access and funding for cancer treatment are also pivotal as they facilitate the establishment of state-of-the-art radiotherapy facilities. Additionally, technological advancements in radiotherapy, including the development of more precise and targeted treatment techniques, are enhancing treatment efficacy and minimizing side effects. The growing collaboration between public and private sectors is driving investments in radiotherapy equipment and training for healthcare professionals, ensuring better service delivery. Lastly, the increasing focus on personalized medicine and minimally invasive treatments is creating a conducive environment for the growth of the radiotherapy market in the region.

Key Highlights of the Market

• The Chile radiotherapy market is expected to witness a CAGR of 6.2% from 2025 to 2035.
• Government initiatives to improve cancer care accessibility are driving market growth.
• Technological advancements are enhancing the efficacy and safety of radiotherapy treatments.
• The rising prevalence of cancer is increasing demand for advanced radiotherapy solutions.
• Collaborations between various sectors are fueling investments in healthcare infrastructure.

By Type of Therapy

External Beam Radiotherapy:

External Beam Radiotherapy (EBRT) is a widely utilized treatment modality in the Chile radiotherapy market, accounting for a significant share due to its effectiveness in targeting tumors with minimal impact on surrounding healthy tissues. This technique involves directing high-energy radiation beams from outside the body onto the cancerous area. EBRT encompasses various techniques such as 3D-conformal radiotherapy, intensity-modulated radiotherapy (IMRT), and stereotactic body radiotherapy (SBRT). The growing adoption of advanced imaging technologies, which enhance the precision of EBRT, is further driving its popularity among oncologists. As the technology evolves, external beam techniques are continuously being refined to optimize treatment delivery and patient outcomes.

Internal Beam Radiotherapy:

Internal Beam Radiotherapy, also referred to as brachytherapy, involves placing a radiation source directly inside or near the tumor. This method allows for localized delivery of radiation, which can be particularly effective for certain types of cancer, such as prostate and cervical cancers. In Chile, the increasing awareness of the benefits of brachytherapy, including shorter treatment times and fewer side effects compared to external beam therapies, is propelling its market growth. Clinicians and patients alike appreciate the efficiency of this therapy, especially in cases where surgery is not a viable option. The rising number of brachytherapy centers in Chile is indicative of this segment’s expanding footprint within the overall radiotherapy landscape.

Systemic Radiotherapy:

Systemic Radiotherapy, which involves the use of radioactive substances administered orally or through injection to target cancer cells throughout the body, is gaining traction in the Chile market. This approach is particularly beneficial for treating cancers that have metastasized or spread to other organs. The increasing prevalence of cancers such as thyroid cancer and certain types of lymphomas has spurred the demand for this therapeutic option. Furthermore, advancements in radiopharmaceuticals are enhancing the effectiveness and safety profiles of systemic radiotherapy, making it a valuable component of cancer treatment protocols in Chile. The growing acceptance of this method by healthcare providers is indicative of its potential to complement traditional radiotherapy modalities.

Others:

Other types of radiotherapy therapies, which may include techniques like radiofrequency ablation and targeted radiotherapy, are also contributing to the growth of the Chile radiotherapy market. These innovative methods often focus on using energy to destroy cancer cells with precision, thus minimizing damage to surrounding tissues. As the healthcare community embraces a more holistic approach to cancer treatment, the integration of these therapies into treatment regimens is becoming more commonplace. Ongoing research and development in the field of radiotherapy are expected to unveil more effective treatment options, further expanding the scope of cancer care in Chile and beyond.

By Cancer Type

Breast Cancer:

Breast cancer remains one of the most prevalent cancer types in Chile, leading to a significant demand for radiotherapy as part of the treatment regimen. Radiotherapy is commonly recommended following surgery to eliminate remaining cancer cells and reduce the risk of recurrence. The increasing awareness surrounding breast cancer screening and the importance of early detection are making it imperative for healthcare institutions to offer comprehensive treatment options, including radiotherapy. Advances in treatment techniques, such as partial breast irradiation, are providing additional choices for patients, allowing for more targeted and less invasive approaches. The Chilean government's focus on women's health initiatives continues to enhance access to these vital radiotherapy services.

Prostate Cancer:

Prostate cancer is another leading cancer type driving the Chile radiotherapy market. The rising incidence of prostate cancer, particularly among older males, has resulted in growing awareness and acceptance of radiotherapy as a primary treatment option. Both external beam radiotherapy and brachytherapy are commonly utilized for managing prostate cancer, each offering unique benefits depending on individual patient circumstances. The combination of state-of-the-art treatment technologies and personalized care is critical in addressing the needs of prostate cancer patients. Furthermore, educational campaigns about prostate cancer are fostering earlier diagnosis and treatment, ultimately promoting higher survival rates in the Chilean population.

Lung Cancer:

Lung cancer is a significant health challenge in Chile, largely attributed to high smoking rates and environmental factors. Radiotherapy plays a crucial role in the management of lung cancer, particularly for patients who are not candidates for surgery or those with advanced-stage disease. Stereotactic radiotherapy techniques are increasingly being employed to deliver precise doses of radiation to tumors while sparing healthy lung tissue, enhancing treatment effectiveness. The growing number of specialized cancer treatment centers equipped with advanced radiotherapy technology is improving access to care for lung cancer patients, addressing a critical need in the healthcare system. Ongoing research into lung cancer treatment is expected to uncover new radiotherapy applications, further cementing its importance in this domain.

Colorectal Cancer:

Colorectal cancer has been recognized as a significant public health concern in Chile, leading to the increased incorporation of radiotherapy in treatment protocols. Radiotherapy is often utilized in conjunction with surgery and chemotherapy to manage localized tumors effectively. The emergence of advanced imaging and treatment planning systems is enabling healthcare providers to deliver more effective radiotherapy solutions for colorectal cancer patients. As screening efforts improve, leading to earlier diagnosis, the role of radiotherapy in the overall treatment landscape is expanding, as it provides an additional layer of care. The integration of multidisciplinary approaches to cancer treatment is becoming more commonplace, ensuring that patients receive tailored, evidence-based care.

Others:

In addition to the aforementioned cancers, various other malignancies, including head and neck cancers, skin cancers, and gynecological cancers, are also contributing to the Chile radiotherapy market. The diversity of cancer types and the unique treatment requirements underscore the necessity for comprehensive radiotherapy services. Advances in treatment technology are accommodating a wider range of cancer types, allowing for more personalized treatment plans that consider individual patient needs and preferences. The multidisciplinary approach to cancer care, which integrates radiotherapy with other treatment modalities, is enhancing patient outcomes across various cancer types, further solidifying the role of radiotherapy in Chile's healthcare landscape.

By End User

Hospitals:

Hospitals are the primary end users of radiotherapy services in Chile, providing comprehensive cancer care through specialized oncology departments. These institutions are typically equipped with advanced radiotherapy technologies, enabling them to deliver a range of treatment options to patients. The increasing investment in healthcare infrastructure by both public and private entities is enhancing hospitals' capacity to provide effective radiotherapy services. Additionally, the collaboration between hospitals and research institutions is driving improvements in treatment protocols and patient management strategies, ultimately leading to better outcomes. The emphasis on patient-centered care within hospitals is also facilitating access to radiotherapy, allowing patients to receive timely and appropriate treatment.

Cancer Treatment Centers:

Cancer treatment centers are emerging as pivotal players in the Chile radiotherapy market, offering specialized services tailored to cancer patients. These centers often provide a more focused approach to oncology care, including advanced radiotherapy techniques and supportive services. The rise of dedicated cancer treatment facilities is addressing the growing demand for comprehensive cancer care, particularly in urban areas where cancer incidence rates are high. By offering a range of treatment options, including clinical trials and integrative therapies, cancer treatment centers are enhancing patient experiences and outcomes. Moreover, their ability to attract skilled oncologists and radiation therapists is contributing to the overall improvement in the quality of care provided to cancer patients in Chile.

Specialty Clinics:

Specialty clinics that focus on specific types of cancer or treatment modalities are also playing an essential role in the radiotherapy market in Chile. These clinics often provide highly specialized services, including targeted radiotherapy and personalized treatment plans, which can lead to improved patient outcomes. The increasing number of specialty clinics is indicative of the growing demand for focused cancer care, as patients seek out centers that can address their specific needs. These clinics are often equipped with the latest technology and staffed by experts in their respective fields, ensuring that patients receive high-quality care. The collaboration between specialty clinics and larger healthcare institutions is fostering a more integrated approach to cancer treatment, further benefiting patients across the spectrum of care.

By Equipment Type

Linear Accelerators:

Linear accelerators (LINACs) are the cornerstone of modern radiotherapy, widely used for delivering external beam radiation to treat various cancers. In Chile, the adoption of LINAC technology has been significant, as these machines offer precision and versatility in treatment delivery. Linear accelerators are capable of administering different types of radiation therapy, including 3D conformal radiotherapy and intensity-modulated radiotherapy (IMRT), which allows for better targeting of tumors while sparing healthy tissue. The ongoing advancements in LINAC technology, such as real-time imaging capabilities and integration with treatment planning systems, are expected to drive continued growth in this segment, enhancing the effectiveness of cancer treatments.

Proton Therapy Systems:

Proton therapy systems represent an advanced approach to radiotherapy, offering the ability to deliver high doses of radiation with minimal damage to surrounding tissues. Although proton therapy is still in its nascent stage in Chile, the growing recognition of its benefits, particularly for pediatric patients and complex tumors, is driving interest in its adoption. The precision of proton therapy is particularly advantageous for tumors located near critical organs, where traditional radiation methods may pose greater risks. Investment in proton therapy facilities is expected to increase as the demand for advanced cancer treatment options rises, enabling Chile to diversify its radiotherapy offerings and provide cutting-edge care to patients.

CyberKnife:

The CyberKnife system is an innovative robotic radiosurgery technology that allows for non-invasive treatment of tumors in various locations throughout the body. This system utilizes real-time imaging and advanced software algorithms to precisely deliver high doses of radiation while compensating for patient movement during treatment. The growing demand for minimally invasive treatment options has resulted in increased interest in CyberKnife technology in Chile, particularly for patients seeking alternatives to traditional surgery. The ability to treat tumors that may be difficult to reach through conventional means is establishing CyberKnife as a valuable addition to the radiotherapy landscape, contributing to improved patient outcomes and quality of life.

Others:

Other equipment types utilized in the Chile radiotherapy market may include specialized brachytherapy devices and emerging technologies designed for targeted radiotherapy treatments. As the field of radiotherapy continues to evolve, the introduction of new equipment and modalities is essential to meet the diverse needs of cancer patients. The integration of advanced imaging and treatment planning technologies is improving the overall effectiveness of radiotherapy, enabling clinicians to deliver more accurate and effective treatments. Additionally, ongoing research and development efforts are expected to yield innovative equipment solutions that will enhance the capabilities of existing treatment facilities in Chile, ultimately improving patient care and outcomes.

By Region

The regional analysis of the Chile radiotherapy market reveals significant insights into the dynamics that influence growth and development. The South American market, particularly Chile, is expected to witness substantial growth in radiotherapy services due to increasing cancer incidence rates and growing public awareness regarding treatment options. By 2035, it is projected that the radiotherapy market in Chile will reach approximately USD 1.2 billion, with a CAGR of 6.5%. This growth will be driven by improved healthcare infrastructure, government initiatives to expand access to cancer treatment, and the adoption of advanced treatment technologies. As healthcare facilities continue to enhance their capabilities, they will be better equipped to meet the rising demand for effective cancer care solutions.

Within Chile, major urban centers such as Santiago, Valparaíso, and Concepción are anticipated to dominate the radiotherapy market due to their concentrated healthcare resources and higher patient populations. The establishment of specialized cancer treatment centers and hospitals in these regions is expected to play a critical role in enhancing radiotherapy access and delivery. Moreover, the Chilean government's commitment to improving cancer care through funding and policy initiatives will likely expedite the growth of radiotherapy services in these areas. As the demand for innovative cancer treatments continues to rise, the regional landscape in Chile is expected to evolve, fostering an environment conducive to advancements in radiotherapy.

Opportunities

The Chile radiotherapy market presents numerous opportunities for growth and development. One of the most promising avenues lies in the expansion of cancer treatment facilities across the country. As awareness of cancer screening and early detection increases, there is a corresponding need for comprehensive cancer care centers equipped with advanced radiotherapy technologies. The collaboration between public and private sectors can facilitate the establishment of new treatment centers, ensuring that patients have access to cutting-edge therapies. Furthermore, partnerships with international organizations and research institutions can pave the way for clinical trials and the introduction of innovative treatment protocols, enhancing the overall quality of cancer care in Chile.

Another significant opportunity is the increasing investment in technology and research aimed at developing novel radiotherapy techniques and equipment. The emphasis on personalized medicine is driving demand for radiotherapy solutions tailored to individual patient needs. As Chilean healthcare providers seek to improve treatment outcomes, investing in advanced imaging technologies, robotic systems, and precise treatment planning tools will be crucial. By leveraging global advancements in radiotherapy, Chile can position itself as a leader in oncology care within the South American region. The growth of telemedicine and remote consultations can also enhance access to specialized cancer care, allowing patients in rural areas to benefit from expert guidance and treatment recommendations.

Threats

Despite the positive growth trajectory of the Chile radiotherapy market, several threats could hinder its progress. One of the prominent challenges is the limited access to advanced radiotherapy technologies in rural areas, where healthcare infrastructure may be lacking. This disparity can lead to unequal treatment opportunities for patients based on their geographical location, resulting in poorer health outcomes for those in underserved regions. Additionally, the high costs associated with advanced radiotherapy equipment and treatments can pose a barrier to access, particularly for low-income patients and those reliant on public healthcare systems. Addressing these disparities will be essential to ensure equitable cancer care across the population.

Another significant threat is the potential for regulatory obstacles that could impede the adoption of new radiotherapy technologies and treatment modalities. Stringent regulatory requirements and lengthy approval processes can delay the introduction of innovative treatments, limiting patients' access to the latest advancements. Furthermore, the complexity of integrating advanced technologies into existing healthcare systems may challenge healthcare providers and institutions. Ensuring that regulatory frameworks support rapid innovation while maintaining patient safety will be crucial in navigating these challenges effectively.

Competitor Outlook

• Varian Medical Systems
• Siemens Healthineers
• Philips Healthcare
• Accuray Incorporated
• GE Healthcare
• Ion Beam Applications (IBA)
• CIVCO Radiotherapy
• ViewRay, Inc.
• RaySearch Laboratories
• Bracco Imaging S.p.A.
• Standard Imaging, Inc.
• Mevion Medical Systems
• Zarbex Radiation Technology
• Nordion Inc.
• Sun Nuclear Corporation

The competitive landscape of the Chile radiotherapy market is characterized by the presence of both global and local players, each striving to establish a foothold in this growing industry. Leading companies such as Varian Medical Systems, Siemens Healthineers, and Philips Healthcare are at the forefront, providing advanced radiotherapy solutions and technologies that cater to the evolving needs of cancer treatment. These companies invest heavily in research and development to introduce innovative radiotherapy equipment and treatment modalities, positioning themselves as key contributors to the market's growth. Their commitment to enhancing patient care through technological advancements, along with strong partnerships with healthcare institutions, further solidifies their standing in the market.

Emerging companies like Accuray Incorporated and ViewRay, Inc. are also making significant strides in the radiotherapy sector, focusing on specialized treatment solutions such as stereotactic radiosurgery and adaptive radiotherapy. These companies are capitalizing on the growing demand for precision and personalized cancer treatment, leveraging their cutting-edge technologies to meet the unique needs of patients. The competitive landscape is also witnessing an increase in collaborations and partnerships between healthcare providers and equipment manufacturers, promoting the exchange of knowledge and expertise that can lead to improved treatment outcomes.

In addition to established players and emerging companies, the Chile radiotherapy market is seeing the involvement of various specialized firms and startups that are contributing to innovation and growth. Companies like CIVCO Radiotherapy and Sun Nuclear Corporation are focusing on developing complementary technologies and solutions that enhance the overall radiotherapy workflow. By addressing the specific challenges faced by healthcare providers, these companies are carving out niches within the competitive landscape. Overall, the Chile radiotherapy market is poised for continued evolution, driven by the combined efforts of various stakeholders committed to advancing cancer care.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Nordion Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GE Healthcare
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ViewRay, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 CIVCO Radiotherapy
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Philips Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Accuray Incorporated
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Siemens Healthineers
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bracco Imaging S.p.A.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Mevion Medical Systems
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 RaySearch Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Standard Imaging, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Varian Medical Systems
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Sun Nuclear Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Ion Beam Applications (IBA)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Zarbex Radiation Technology
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Chile Radiotherapy Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Cancer Treatment Centers
    • 6.1.3 Specialty Clinics
  • 6.2 Chile Radiotherapy Market, By Cancer Type
    • 6.2.1 Breast Cancer
    • 6.2.2 Prostate Cancer
    • 6.2.3 Lung Cancer
    • 6.2.4 Colorectal Cancer
    • 6.2.5 Others
  • 6.3 Chile Radiotherapy Market, By Equipment Type
    • 6.3.1 Linear Accelerators
    • 6.3.2 Proton Therapy Systems
    • 6.3.3 CyberKnife
    • 6.3.4 Others
  • 6.4 Chile Radiotherapy Market, By Type of Therapy
    • 6.4.1 External Beam Radiotherapy
    • 6.4.2 Internal Beam Radiotherapy
    • 6.4.3 Systemic Radiotherapy
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Chile Radiotherapy Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Chile Radiotherapy market is categorized based on

By Type of Therapy

• External Beam Radiotherapy
• Internal Beam Radiotherapy
• Systemic Radiotherapy
• Others

By Cancer Type

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Others

By End User

• Hospitals
• Cancer Treatment Centers
• Specialty Clinics

By Equipment Type

• Linear Accelerators
• Proton Therapy Systems
• CyberKnife
• Others

By Region

• South America

Key Players

• Varian Medical Systems
• Siemens Healthineers
• Philips Healthcare
• Accuray Incorporated
• GE Healthcare
• Ion Beam Applications (IBA)
• CIVCO Radiotherapy
• ViewRay, Inc.
• RaySearch Laboratories
• Bracco Imaging S.p.A.
• Standard Imaging, Inc.
• Mevion Medical Systems
• Zarbex Radiation Technology
• Nordion Inc.
• Sun Nuclear Corporation